Structural and Energetic Mechanisms of Cooperative Autoinhibition and Activation of Vav1

Vav proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases. They control processes including T cell activation, phagocytosis, and migration of normal and transformed cells. We report the structure and biophysical and cellular analyses of the five-domain autoinhibitory element of Vav1. The catalytic Dbl homology (DH) domain of Vav1 is controlled by two energetically coupled processes. The DH active site is directly, but weakly, inhibited by a helix from the adjacent Acidic domain. This core interaction is strengthened 10-fold by contacts of the calponin homology (CH) domain with the Acidic, pleckstrin homology, and DH domains. This construction enables efficient, stepwise relief of autoinhibition: initial phosphorylation events disrupt the modulatory CH contacts, facilitating phosphorylation of the inhibitory helix and consequent GEF activation. Our findings illustrate how the opposing requirements of strong suppression of activity and rapid kinetics of activation can be achieved in multidomain systems.

[1]  P. Leibson,et al.  Specific Subdomains of Vav Differentially Affect T Cell and NK Cell Activation1 , 2000, The Journal of Immunology.

[2]  Greg L. Hura,et al.  Structural basis of guanine nucleotide exchange mediated by the T-cell essential Vav1. , 2008, Journal of molecular biology.

[3]  M. Glogauer,et al.  Requirements for Vav guanine nucleotide exchange factors and Rho GTPases in FcgammaR- and complement-mediated phagocytosis. , 2006, Immunity.

[4]  E. Álava,et al.  Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction , 2006, Nature Medicine.

[5]  Jack Snoeyink,et al.  Nucleic Acids Research Advance Access published April 22, 2007 MolProbity: all-atom contacts and structure validation for proteins and nucleic acids , 2007 .

[6]  Harald Schwalbe,et al.  NMR characterization of kinase p38 dynamics in free and ligand-bound forms. , 2006, Angewandte Chemie.

[7]  M. Barbacid,et al.  vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells. , 1989, The EMBO journal.

[8]  W. Swat,et al.  Vav1 Acidic Region Tyrosine 174 Is Required for the Formation of T Cell Receptor-induced Microclusters and Is Essential in T Cell Development and Activation* , 2006, Journal of Biological Chemistry.

[9]  Wolfgang Jahnke,et al.  Solution Conformations and Dynamics of ABL Kinase-Inhibitor Complexes Determined by NMR Substantiate the Different Binding Modes of Imatinib/Nilotinib and Dasatinib*♦ , 2008, Journal of Biological Chemistry.

[10]  Nathaniel J. Traaseth,et al.  Allosteric cooperativity in protein kinase A , 2008, Proceedings of the National Academy of Sciences.

[11]  Wladek Minor,et al.  HKL-3000: the integration of data reduction and structure solution--from diffraction images to an initial model in minutes. , 2006, Acta crystallographica. Section D, Biological crystallography.

[12]  Giulio Superti-Furga,et al.  Dynamic Coupling between the SH2 and SH3 Domains of c-Src and Hck Underlies Their Inactivation by C-Terminal Tyrosine Phosphorylation , 2001, Cell.

[13]  Xin-Yun Huang,et al.  Structural Basis for Relief of Autoinhibition of the Dbl Homology Domain of Proto-Oncogene Vav by Tyrosine Phosphorylation , 2000, Cell.

[14]  Benoît Roux,et al.  On the importance of a funneled energy landscape for the assembly and regulation of multidomain Src tyrosine kinases , 2007, Proceedings of the National Academy of Sciences.

[15]  V. Tybulewicz,et al.  Vav-family proteins in T-cell signalling. , 2005, Current opinion in immunology.

[16]  G. Amarasinghe,et al.  Internal dynamics control activation and activity of the autoinhibited Vav DH domain , 2008, Nature Structural &Molecular Biology.

[17]  K. Rittinger,et al.  Crucial structural role for the PH and C1 domains of the Vav1 exchange factor , 2008, EMBO reports.

[18]  X. Bustelo.  Vav proteins, adaptors and cell signaling , 2001, Oncogene.

[19]  Eric C. Griffith,et al.  Vav Family GEFs Link Activated Ephs to Endocytosis and Axon Guidance , 2005, Neuron.

[20]  Holger Sondermann,et al.  Structural Analysis of Autoinhibition in the Ras Activator Son of Sevenless , 2004, Cell.

[21]  W. Lim,et al.  Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. , 2000, Science.

[22]  M. Vijayan,et al.  Isomorphous replacement and anomalous scattering , 2006 .

[23]  M. White,et al.  Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. , 1998, Science.

[24]  John Kuriyan,et al.  A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain , 2006, PLoS biology.

[25]  Dmitry M Korzhnev,et al.  Probing slow dynamics in high molecular weight proteins by methyl-TROSY NMR spectroscopy: application to a 723-residue enzyme. , 2004, Journal of the American Chemical Society.

[26]  J. Kuriyan,et al.  Activation of the Sire-family tyrosine kinase Hck by SH3 domain displacement , 1997, Nature.

[27]  P. Chacón,et al.  Multi-resolution contour-based fitting of macromolecular structures. , 2002, Journal of molecular biology.

[28]  D. Kern,et al.  Dynamic personalities of proteins , 2007, Nature.

[29]  G. Amarasinghe,et al.  Acidic region tyrosines provide access points for allosteric activation of the autoinhibited Vav1 Dbl homology domain. , 2005, Biochemistry.

[30]  Pramodh Vallurupalli,et al.  A single-quantum methyl 13C-relaxation dispersion experiment with improved sensitivity , 2007, Journal of biomolecular NMR.

[31]  L. Kay,et al.  Cross-correlated relaxation enhanced 1H[bond]13C NMR spectroscopy of methyl groups in very high molecular weight proteins and protein complexes. , 2003, Journal of the American Chemical Society.

[32]  M. Revelo,et al.  Vav3 oncogene is overexpressed and regulates cell growth and androgen receptor activity in human prostate cancer. , 2006, Molecular endocrinology.

[33]  P. Seeburg,et al.  Structural mechanism for STI-571 inhibition of abelson tyrosine kinase. , 2000, Science.

[34]  P. Evans,et al.  Scaling and assessment of data quality. , 2006, Acta crystallographica. Section D, Biological crystallography.

[35]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[36]  D. Lambright,et al.  Structural basis and mechanism of autoregulation in 3-phosphoinositide-dependent Grp1 family Arf GTPase exchange factors. , 2007, Molecular cell.

[37]  E. Arias-Palomo,et al.  Global conformational rearrangements during the activation of the GDP/GTP exchange factor Vav3 , 2005, The EMBO journal.

[38]  T. Mayadas,et al.  Vav Proteins in Neutrophils Are Required for FcγR-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox)1 , 2006, The Journal of Immunology.

[39]  Randy J Read,et al.  Electronic Reprint Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination Biological Crystallography Phenix: Building New Software for Automated Crystallographic Structure Determination , 2022 .

[40]  J. Cleveland,et al.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential , 1991, Molecular and cellular biology.

[41]  X. Bustelo,et al.  Tyrosine Phosphorylation Mediates Both Activation and Downmodulation of the Biological Activity of Vav , 2000, Molecular and Cellular Biology.

[42]  Victor S Lamzin,et al.  Breaking good resolutions with ARP/wARP. , 2004, Journal of synchrotron radiation.

[43]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[44]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[45]  George M Sheldrick,et al.  Substructure solution with SHELXD. , 2002, Acta crystallographica. Section D, Biological crystallography.

[46]  S. Katzav,et al.  Flesh and blood: the story of Vav1, a gene that signals in hematopoietic cells but can be transforming in human malignancies. , 2007, Cancer letters.

[47]  K. Rossman,et al.  Role of the C-terminal SH3 domain and N-terminal tyrosine phosphorylation in regulation of Tim and related Dbl-family proteins. , 2008, Biochemistry.

[48]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[49]  C. Der,et al.  Involvement of NH2-terminal Sequences in the Negative Regulation of Vav Signaling and Transforming Activity* , 1999, The Journal of Biological Chemistry.